Biomarkers for abnormal eye blood vessels
Part of Eyes & vision, Hormones & metabolism clinical trials.
This study is looking for biomarkers (clues in your body) related to abnormal blood vessels in the eye. It may help researchers understand and treat conditions like macular degeneration.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have abnormal blood vessels under your retina (called choroidal neovascularization) caused by either central serous chorioretinopathy or age-related macular degeneration.
- You should not have had an eye injection in the last 3 months.
- You cannot have other serious health problems like diabetes, kidney failure, inflammatory disease, or certain infections (HIV, hepatitis, tuberculosis).
- You cannot be pregnant.
- If you don't have abnormal blood vessels, you must be having eye surgery (for cataracts or a vitrectomy) to join the other group.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new ways to diagnose and track eye disorders using imaging and genetic tests. It may help find better treatments for conditions linked to blood vessel and nerve problems in the eye.
This study looks at a specific lab marker (sCD160) in blood and eye fluids to see how it relates to poor blood flow in the retina. You may be asked for samples taken during eye surgery to help doctors understand the disease better.
This study looks for biological markers in the blood or eye samples of people with rare eye diseases compared to healthy volunteers. It aims to better understand and diagnose these conditions.
This study follows people with “birdshot chorioretinopathy,” a rare eye inflammation, and collects immune (genetic) information to better understand the disease. You may benefit from closer monitoring, and the results may help guide future treatments.
This study looks at substances (“biomarkers”) in the clear fluid inside the eye to better understand several eye conditions that affect vision. Your results may help doctors learn how these diseases work and how treatments might be chosen.
This study uses an advanced eye scan (OCT-A) to look at tiny blood vessels in the back of the eye. It compares people with systemic blood vessel conditions (like high blood pressure or inflammatory disease) to healthy volunteers, to see if the eye scan can help predict or understand these diseases.
Hear when a new Choroidal Neovascularization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.